Literature DB >> 8013491

Mechanisms of failure to decontaminate the gut with polymixin E, gentamicin and amphotericin B in patients in intensive care.

B Misset1, M D Kitzis, G Conscience, F Goldstein, A Fourrier, J Carlet.   

Abstract

The objective of the present work was to assess the possible mechanisms of the poor efficiency of selective decontamination of the digestive tract (SDD) in medical and surgical intensive care unit (ICU) patients. Sixty-four consecutive mechanically ventilated patients received gut decontamination with polymixin E, gentamicin and amphotericin B via a nasogastric tube and were assessed for oropharyngeal, gastric and fecal colonization and for the presence of each antibiotic in the stomach and feces. A decrease in fecal colonization with Escherichia coli was observed over 20 days but not with other gram-negative bacteria or gram-positive cocci. Fifteen and 26% of the fecal colonizing gram-negative bacteria were resistant to polymixin E and gentamicin, respectively, at admission. These proportions increased to up to 50% after 16 days of treatment. Although 50% of staphylococci were initially sensitive to gentamicin, all strains were resistant to this drug after four days of SDD. Both antibiotics were found in concentrations of less than 20 micrograms/g in 11 of 38 stools. Of these 38 stools, nine were not contaminated, 20 were colonized with resistant bacteria and 16 with strains sensitive to one antibiotic present in the stool. Therefore, the poor efficiency of gut decontamination observed was probably due to the great proportion of resistant strains on admission of the patients, to the selection of such resistant strains with SDD, to poor intestinal transit of the antibiotics, and to inactivation of the drugs by the feces. These results support stringent monitoring of fecal colonization in patients undergoing SDD in order to detect the fecal carriage of gram-positive and multiresistant gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013491     DOI: 10.1007/bf01982192

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract.

Authors:  H Gastinne; M Wolff; F Delatour; F Faurisson; S Chevret
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

2.  Selective decontamination of the digestive tract in Kuwait.

Authors:  F M Abu-Zidan; E McAteer; K M Elhag
Journal:  Crit Care Med       Date:  1989-12       Impact factor: 7.598

Review 3.  Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.

Authors:  I M Ledingham; S R Alcock; A T Eastaway; J C McDonald; I C McKay; G Ramsay
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

4.  A simplified acute physiology score for ICU patients.

Authors:  J R Le Gall; P Loirat; A Alperovitch; P Glaser; C Granthil; D Mathieu; P Mercier; R Thomas; D Villers
Journal:  Crit Care Med       Date:  1984-11       Impact factor: 7.598

5.  The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients.

Authors:  C P Stoutenbeek; H K van Saene; D R Miranda; D F Zandstra
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

6.  Intestinal decontamination in a polyvalent ICU. A double-blind study.

Authors:  J Godard; C Guillaume; M E Reverdy; P Bachmann; B Bui-Xuan; A Nageotte; J Motin
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis.

Authors:  K Unertl; G Ruckdeschel; H K Selbmann; U Jensen; H Forst; F P Lenhart; K Peter
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

8.  Nosocomial infections in intensive care wards: a multicenter prospective study.

Authors:  F D Daschner; P Frey; G Wolff; P C Baumann; P Suter
Journal:  Intensive Care Med       Date:  1982-01       Impact factor: 17.440

9.  Risk factors for postoperative pneumonia.

Authors:  R A Garibaldi; M R Britt; M L Coleman; J C Reading; N L Pace
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

10.  Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study.

Authors:  C Ulrich; J E Harinck-de Weerd; N C Bakker; K Jacz; L Doornbos; V A de Ridder
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

View more
  6 in total

1.  Selective decontamination of the digestive tract: to stimulate or stifle?

Authors:  Marc J M Bonten; Christian Brun-Buisson; Robert A Weinstein
Journal:  Intensive Care Med       Date:  2003-05       Impact factor: 17.440

2.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene.

Authors:  Wolfgang A Krueger; Alexandra Heininger; Béatrice Grabein; Klaus Unertl; Miguel Sánchez-García
Journal:  Antimicrob Agents Chemother       Date:  2014-06       Impact factor: 5.191

4.  Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".

Authors:  Teysir Halaby; Nashwan Al Naiemi; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Agents Chemother       Date:  2014-06       Impact factor: 5.191

5.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

Review 6.  Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review.

Authors:  Jw Olivier van Till; Oddeke van Ruler; Bas Lamme; Roy J P Weber; Johannes B Reitsma; Marja A Boermeester
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.